VolitionRX Profit Margin

VolitionRX (VNRX) currently reports a profit margin of -1043.11% as of June 2026. That compares with -1767.88% in the prior-year period — up 41.0% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore VolitionRX's profit margin history and peer comparisons.

VolitionRX's profit margin increased from -1767.88% to -1043.11% — a 41.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VolitionRX's profit margin of -1043.11% is lower than the Healthcare sector average of 13.76%. That is roughly 7680.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but VolitionRX's current -1043.11% should be judged against Healthcare norms (sector average: 13.76%) and against VNRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1043.11%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for VolitionRX, and consider following VNRX for alerts when major investors trade the stock.